BTG (BTG)

Sector: Biotechnology     Index: FTSE 250
-0.62%
-4.00p
640.50p
16:35 04/09/15

   Spread betting | CFDs | Stockbroking   Trade now with IG Sponsored by IG. Losses can exceed deposits

640.50p
16:35 04/09/15
DAILY VARIATION
-0.62%
-4.00p
VOLUME
400,692
REAL TIME BATS
640.50p
16:35 04/09/15
-0.62%
-4.00p
DATA
52 Week High
830.00p
52 Week Low
592.00p
Shares Issued
382.82m
Market Cap
£2,415.56m
RiskGrade
n/a
Beta
0.63
MENU

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 9.5% 18.3%
ROCE 26.7%
Latest F'cast
P/E 40.8 31.9
PEG 4.9 1.4
Pr/Revenue 6.7 5.6
Pr/Book 3.2
Latest F'cast
Revenue 26.6% 12.3%
PBT -19.8% n/a
EPS 8.3% -10.4%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2011-03-31 111.40 -10.80 1.00p 227.6 -2.7 -86% n/a 0.0%
2012-03-31 197.00 23.00 11.40p 29.3 0.0 1,040% n/a 0.0%
2013-03-31 233.70 24.10 14.50p 24.6 0.9 27% n/a 0.0%
2014-03-31 290.50 33.30 14.50p 37.4 0.0 n/a n/a 0.0%
2015-03-31 367.80 26.70 15.70p 45.5 5.5 8% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2016-03-31 441.16 80.58 19.49p 31.9 1.3 24% 0.00p 0.0%
2017-03-31 516.60 123.33 27.50p 23.1 0.6 41% 0.00p 0.0%

Regulatory News

slide to see more
Holding(s) in Company 01-Sep-15 17:25
Total Voting Rights 01-Sep-15 15:24
Holding(s) in Company 27-Aug-15 15:50

Newspaper Links

No results found